Journal of Clinical Pediatrics ›› 2026, Vol. 44 ›› Issue (3): 252-257.doi: 10.12372/jcp.2026.25e1032
• Clinical Report • Previous Articles Next Articles
SHEN Yiyi, QIAN Xueying, ZHENG Yucan, LU Yan, LIU Zhifeng, ZHANG Zhihua(
)
Received:2025-08-22
Accepted:2026-01-23
Published:2026-03-15
Online:2026-03-06
CLC Number:
SHEN Yiyi, QIAN Xueying, ZHENG Yucan, LU Yan, LIU Zhifeng, ZHANG Zhihua. Disseminated Trichosporon asahii infection mainly manifested as digestive system infection of a child: a case report and literature review[J].Journal of Clinical Pediatrics, 2026, 44(3): 252-257.
| [1] | Duarte-Oliveira C, Rodrigues F, Gonçalves SM, et al. The cell biology of the Trichosporon-Host interaction[J]. Front Cell Infect Microbiol, 2017, 7: 118. |
| [2] | 杨蓉娅, 王文岭, 敖俊红, 等. 国内阿萨希毛孢子菌首次分离及鉴定[J]. 中国医师杂志, 2002(2): 159-160. |
| Yang RY, Wang WL, Ao JH, et al. The First isolation and identification of Trichosporon Asahii in China[J]. Zhongguo Yishi Zazhi, 2002(2): 159-160. | |
| [3] |
Desnos-Ollivier M, Maufrais C, Pihet M, et al. Epidemio-logical investigation for grouped cases of Trichosporon asahii using whole genome and IGS1 sequen-cing[J]. Mycoses, 2020, 63(9): 942-951.
doi: 10.1111/myc.13126 pmid: 32506754 |
| [4] |
de Almeida Júnior JN, Hennequin C. Invasive trichosporon infection: a systematic review on a re-emerging fungal pathogen[J]. Front Microbiol, 2016, 7: 1629.
pmid: 27799926 |
| [5] | Kim YJ, Kim SI, Kim YR, et al. Successful treatment of septic shock with purpura fulminans caused by Trichosporon asahii in an immunocompetent patient[J]. Ann Clin Lab Sci, 2007, 37(4): 366-369. |
| [6] |
Nett JE, Andes DR. Antifungal agents: spectrum of activity, pharmacology, and clinical indications[J]. Infect Dis Clin North Am, 2016, 30(1): 51-83.
doi: 10.1016/j.idc.2015.10.012 |
| [7] |
Sun W, Su J, Xu S et al. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing[J]. J Med Microbiol, 2012, 61(Pt 12): 1750-1757.
doi: 10.1099/jmm.0.049817-0 pmid: 22956749 |
| [8] |
Mahoney D, Aftandilian C. Breakthrough Trichosporon asahii in a patient with new diagnosis B-ALL on echinocandin prophylaxis: a case report[J]. J Pediatr Hematol Oncol, 2022, 44(2): e514-e517.
doi: 10.1097/MPH.0000000000002339 pmid: 35200226 |
| [9] |
Yang F, Feng J, Wang L, et al. Disseminated Trichosporon asahii infection presenting as eosinophilia in an immunocompetent patient: A case report[J]. Indian J Med Microbiol, 2021, 39(4): 552-555.
doi: 10.1016/j.ijmmb.2021.05.021 |
| [10] |
Raju DS, Sugunan A, Keechilattu P, et al. Chemoport-related fungemia caused by Trichosporon asahii[J]. J Pediatr Hematol Oncol, 2019, 42(3): e193-e194.
doi: 10.1097/MPH.0000000000001420 |
| [11] |
Galligan ER, Fix L, Husain S, et al. Disseminated trichosporonosis with atypical histologic findings in a patient with acute lymphocytic leukemia[J]. J Cutan Pathol, 2018, 46(2): 159-161.
doi: 10.1111/cup.2019.46.issue-2 |
| [12] | Nguyen JK, Schlichte MJ, Schady D, et al. Fatal disseminated Trichosporon asahii fungemia in a child with acute lymphoblastic leukemia and a morbilliform eruption[J]. Pediatr Dermatol, 2017, 35(1): e86-e87. |
| [13] |
Kumar A, Udayakumaran S, Babu R, et al. Trichosporon asahii infection presenting as chronic meningo-ventriculitis and intra ventricular fungal ball: a case report and literature review[J]. Mycoses, 2015, 58(2): 99-103.
doi: 10.1111/myc.12282 pmid: 25590228 |
| [14] |
Maxfield L, Matthews JJ, Ambrosetti DR, et al. Tricho-sporon fungemia in a pediatric patient with acute lymphoblastic leukemia[J]. IDCases, 2015, 2(4): 106-108.
doi: 10.1016/j.idcr.2015.09.007 pmid: 26793473 |
| [15] | Tanyildiz HG, Yesil S, Toprak S, et al. Two case presentations infected by Trichosporon asahii and treated with voriconazole successfully[J]. Case Rep Infect Dis, 2015, 2015: 651315. |
| [16] |
Negi V, Sharma M, Juyal D, et al. Disseminated trichosporonosis due to Trichosporon asahii in a diabetic patient[J]. Indian J Pathol Microbiol, 2015, 58(2): 246-248.
doi: 10.4103/0377-4929.155333 |
| [17] |
Karapinar DY, Karadaş N, Yazici P, et al. Trichosporon asahii, sepsis, and secondary hemophagocytic lymphohistiocytosis in children with hematologic malignancy[J]. Pediatr Hematol Oncol, 2014, 31(3): 282-284.
doi: 10.3109/08880018.2013.851754 pmid: 24383917 |
| [18] |
Ozkaya-Parlakay A, Karadag-Oncel E, Cengiz AB, et al. Trichosporon asahii sepsis in a patient with pediatric malignancy[J]. J Microbiol Immunol Infect, 2013, 49(1): 146-149.
doi: 10.1016/j.jmii.2013.01.003 |
| [19] | 郑晓丽, 王志东, 闫洪敏, 等. 异基因造血干细胞移植过程中并发播散性阿萨希毛孢子菌感染1例并文献复习[J]. 临床血液学杂志, 2013, 26(5): 312-314. |
| Zheng XL, Wang ZD, Yan HM, et al. Disseminated trichosporon asahii infection in an aplastic anemia patient underwen t unrelated hematopoietic stem cell transplantation: a case report and literature review[J]. Linchuang Xueyexue Zazhi, 2013, 26(5):312-314. | |
| [20] |
Kudo K, Terui K, Sasaki S, et al. Voriconazole for both successful treatment of disseminated Trichosporon asahii infection and subsequent cord blood transplantation in an infant with acute myelogenous leukemia[J]. Bone Marrow Transplant, 2011, 46(2): 310.
doi: 10.1038/bmt.2010.96 |
| [21] |
Hosoki K, Iwamoto S, Kumamoto T, et al. Early detection of breakthrough trichosporonosis by serum PCR in a cord blood transplant recipient being prophylactically treated with voriconazole[J]. J Pediatr Hematol Oncol, 2008, 30(12): 917-919.
doi: 10.1097/MPH.0b013e3181864aa7 pmid: 19131780 |
| [22] |
Tsuji Y, Tokimatsu I, Sugita T, et al. Quantitative PCR assay used to monitor serum Trichosporon asahii DNA concentrations in disseminated trichosporonosis[J]. Pediatr Infect Dis J, 2008, 27(11): 1035-1037.
doi: 10.1097/INF.0b013e318179260d |
| [23] |
Thibeault R, Champagne M, de Repentigny L, et al. Fatal disseminated Trichosporon asahii infection in a child with acute lymphoblastic leukemia[J]. Can J Infect Dis Med Microbiol, 2008, 19(2): 203-205.
doi: 10.1155/cjid.v19.2 |
| [24] | Ghiasian SA, Maghsood AH, Mirhendi SH. Disseminated, fatal Trichosporon asahii infection in a bone marrow transplant recipient[J]. J Microbiol Immunol Infect, 2006, 39(5): 426-429. |
| [25] |
Antachopoulos C, Papakonstantinou E, Dotis J, et al. Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazole[J]. J Pediatr Hematol Oncol, 2005, 27(5): 283-285.
pmid: 15891566 |
| [26] |
Meyer MH, Letscher-Bru V, Waller J, et al. Chronic disseminated Trichosporon asahii infection in a leukemic child[J]. Clin Infect Dis, 2002, 35(2): e22-e25.
doi: 10.1086/340983 pmid: 12087540 |
| [27] |
Itoh T, Hosokawa H, Kohdera U, et al. Disseminated infection with Trichosporon asahii[J]. Mycoses, 1996, 39(5-6): 195-199.
pmid: 8909029 |
| [28] |
Khan MID, Sahni BAK, Basu CA, et al. Trichosporon asahii urinary tract infection in immunocompetent patients[J]. Medical Journal Armed Forces India, 2015, 71(4): 373-376.
doi: 10.1016/j.mjafi.2014.08.013 |
| [29] |
Al Momani M, Yusef DH, Hamasha D, et al. Complicated Trichosporon asahii mastoiditis in immunocompetent child[J]. BMC Infectious Diseases, 2021, 21(1): 1-4.
doi: 10.1186/s12879-020-05706-z |
| [30] |
Almeida JND, Moreno L, Francisco EC, et al. Trichosporon asahii superinfections in critically ill COVID patients overexposed to antimicrobials and corticosteroids[J]. Mycoses, 2021: 64(8): 817-822.
doi: 10.1111/myc.v64.8 |
| [31] |
Mina S, Yaakoub H, Annweiler C, et al. COVID-19 and fungal infections: a double debacle[J]. Microbes Infect, 2022, 24(8): 105039.
doi: 10.1016/j.micinf.2022.105039 |
| [32] | Chang D, Harfouch CW, Melendez ML. Trichosporon asahii opportunistic pneumonia after a severe COVID-19 infection[J]. IDCases, 2023, 31: e1701. |
| [33] |
Diane Rivet-Danon, Juliette Guitard, Frederic Grenouillet, et al. Rapid diagnosis of cryptococcosis using an antigen detection immunochromatographic test. J Infect, 2015, 70(5): 499-503.
doi: 10.1016/j.jinf.2014.12.017 pmid: 25597824 |
| [34] | Liao Y, Lu X, Yang S, et al. Epidemiology and outcome of Trichosporon Fungemia: a review of 185 reported cases from 1975 to 2014[J]. Open Forum Infect Dis, 2015, 2(4): ofv141. |
| [35] |
Miceli MH, Diaz JA, Lee SA. Emerging opportunistic yeast infections[J]. Lancet Infect Dis, 2011, 11(2): 142-151.
doi: 10.1016/S1473-3099(10)70218-8 pmid: 21272794 |
| [36] | Francisco EC, de Almeida Junior JN, Queiroz-Telles F, et al. Correlation of Trichosporon asahii genotypes with anatomical sites and antifungal susceptibility profiles: data analyses from 284 isolates collected in the last 22 years across 24 medical centers[J]. Antimicrob Agents Chemother, 2021, 65(3): e01104-20. |
| [37] | 张德全, 夏志宽, 敖俊红, 等. 阿萨希毛孢子菌感染治疗新进展[J]. 中国皮肤性病学杂志, 2015, 29(8): 861-863. |
| Zhang DQ, Xia ZK, Ao JH, et al. Recent progress in anti-infective therapy of Trichosporon Asahii[J]. Zhongguo Pifu Xingbingxue Zazhi, 2015, 29(8): 861-863. | |
| [38] |
DE Almeida JJ, Hennequin C. Invasive trichosporon infection: a systematic review on a re-emerging fungal pathogen[J]. Front Microbiol, 2016, 7: 1629.
pmid: 27799926 |
| [39] | Yang RY, Wang WL, Ao JH, et al. Pathogenicity of Trichosporon asahii in a murine model of disseminated trichosporonosis[J]. Chin Med J (Engl), 2008, 121(24): 2557-2560. |
| [40] |
Li H, Qiao J, Wan Z, et al. In vitro interaction of itraconazole with amphotericin B, caspofungin, and terbinafine against clinical isolates of Trichosporon asahii[J]. Mycopathologia, 2011, 171(5): 345-348.
doi: 10.1007/s11046-010-9384-4 |
| [1] | HUANG Wenchen, FENG Yijie, WANG Xiaoyi, YAO Mei, MAO Shanshan. Clinical analysis of two cases of spinal muscular atrophy caused by structural variations in exon 1 and literature review [J]. Journal of Clinical Pediatrics, 2026, 44(3): 185-191. |
| [2] | LIN Yuan, LI Huarong, CHEN Chaoying. Clinicopathological features and prognosis of eight children with coexisting IgA nephropathy and membranous nephropathy: retrospective case series report [J]. Journal of Clinical Pediatrics, 2026, 44(3): 202-208. |
| [3] | ZHANG Shaoli, KANG Ping, TIAN Ming, YANG Jianwei, SUN Hongqi, YANG Junmei, ZHANG Liming. Clinical analysis of ANCA-associated vasculitis presenting with diffuse alveolar hemorrhage syndrome as the initial manifestation [J]. Journal of Clinical Pediatrics, 2026, 44(3): 229-235. |
| [4] | HU Jiaqi, XIAO Jianwen. TTMV::RARA positive acute promyelocytic leukemia in children: a case report and literature review [J]. Journal of Clinical Pediatrics, 2026, 44(3): 236-243. |
| [5] | FANG Hui, YANG Cuicui, SUN Ningning, ZHOU Jiexin, ZHAO Xiaofeng, FANG Ying. Primary intestinal lymphangiectasia with thoracic duct obstruction in a child: a case report [J]. Journal of Clinical Pediatrics, 2026, 44(3): 248-251. |
| [6] | LU Dingjie, WANG Yu. Research progress on comorbidity of attention deficit hyperactivity disorder and mood disorders [J]. Journal of Clinical Pediatrics, 2026, 44(3): 258-263. |
| [7] | GAN Xinyan, LI Xiang, QIU Qianyi, CHEN Fang. Progress in prevention and management strategies of postoperative nausea and vomiting in pediatric day surgery [J]. Journal of Clinical Pediatrics, 2026, 44(3): 270-276. |
| [8] | HUANG Guolan, XIE Yongping, YANG Huazhen, HUANG Lisu. Brain abscess caused by Porphyromonas endodontalis and various anaerobes [J]. Journal of Clinical Pediatrics, 2026, 44(3): 244-247. |
| [9] | NIU Yanhua, DONG Xiaoyan. Clinical characteristics and risk factors for plastic bronchitis in children with macrolide-resistant Mycoplasma pneumoniae pneumonia [J]. Journal of Clinical Pediatrics, 2026, 44(2): 111-117. |
| [10] | LI Yun, GAO Hongbo, DI Yuqing, LI Longmin, LIU Haichun, ZHANG Xiaoyong, SHAO Yujun. Clinical characteristics and prognosis of metastatic pheochromocytoma and paraganglioma in children and adolescents [J]. Journal of Clinical Pediatrics, 2026, 44(2): 118-123. |
| [11] | LI Huarong, CHEN Chaoying, TU Juan, LIN Tiantian, WANG Nannan. Four cases of C3 glomerulopathy in children and literature review [J]. Journal of Clinical Pediatrics, 2026, 44(2): 139-145. |
| [12] | LI Ming, YUE Tong, WEN Min, WU Feifei, ZHANG Dan, XU Yingjie, KANG Min, ZHU Jia, YAN Yuchun, LAI Jianming, WU Fengqi. Clinical characteristics of Behcet syndrome with cardiovascular aneurysms in children [J]. Journal of Clinical Pediatrics, 2026, 44(2): 146-153. |
| [13] | LIANG Haodong, GUO Shengxuan, HU Siyuan, LU Xuanjun, ZHANG Yunhan, XU Chenxia. Research progress of the symptom scale for acute upper respiratory tract infection in children [J]. Journal of Clinical Pediatrics, 2026, 44(2): 161-166. |
| [14] | Subspecialty Pediatric Consensus Collaborative Group, Subspecialty Group of Infectious Diseases, Society of Pediatric, Chinese Medical Association, Subspecialty Group of Infectious Diseases, Society of Pediatric, Zhejiang Medical Association, National Clinical Research Center for Children and Adolescents' Health and Diseases. Expert consensus on the clinical application and individualized therapy of oxazolidinone antibiotics in children [J]. Journal of Clinical Pediatrics, 2026, 44(1): 1-16. |
| [15] | CHEN Dan, REN Jiaying, SUN Lifang, WEI Zhenghu, SUN Xiaomin. Clinical features and prognosis of severe Mycoplasma pneumoniae pneumonia combined with intracardiac thrombus in children: a single-center retrospective study [J]. Journal of Clinical Pediatrics, 2026, 44(1): 17-24. |
|
||